Santiago Rivera1, Nicolás Vecchio2, Paz Ricapito2, Felix Ayala-Paredes3. 1. Cardiovascular Institute of Buenos Aires (ICBA), Ciudad Autonoma de Buenos Aires, 6302 Libertador Av., C1428DCO, Buenos Aires, Argentina. riv.santiago@gmail.com. 2. Cardiovascular Institute of Buenos Aires (ICBA), Ciudad Autonoma de Buenos Aires, 6302 Libertador Av., C1428DCO, Buenos Aires, Argentina. 3. Centre Hospitalaire Universitaire de Sherbrooke (CHUS), Quebec, Canada.
Abstract
BACKGROUND: Catheter ablation of ventricular arrhythmias (VAs) arising from the left ventricular Summit (LVS) is challenging and requires high-dose fluoroscopy to limit vascular damage of the coronary arteries. Ionizing radiation can increase the incidence of malignancies to both patient and operator. This study describes outcomes of catheter ablation of LVS VAs using intracardiac echo-facilitated 3D electroanatomical mapping (ICE-3D) to avoid fluoroscopy. METHODS: Twenty-six patients (47 ± 17 years old; 52% males; median ejection fraction 55 ± 13%) with premature ventricular contractions or ventricular tachycardia underwent catheter ablation. VAs were localized using ICE-3D with arrhythmia foci being mapped at the LVS. Focal ablation was performed using a 3.5-mm open-irrigated, contact force sensing radiofrequency catheter. RESULTS: Acute success and recurrence rates were 84% and 24%, respectively. Holter burden was significantly reduced (24 ± 15% to 1.5 ± 2%; P = 0.01) after ablation. The use of zero fluoroscopy was achieved in 100% of cases. No major complications were observed. CONCLUSIONS: Zero fluoroscopy catheter ablation of LVS VAs using ICE-3D mapping is feasible and effective.
BACKGROUND: Catheter ablation of ventricular arrhythmias (VAs) arising from the left ventricular Summit (LVS) is challenging and requires high-dose fluoroscopy to limit vascular damage of the coronary arteries. Ionizing radiation can increase the incidence of malignancies to both patient and operator. This study describes outcomes of catheter ablation of LVS VAs using intracardiac echo-facilitated 3D electroanatomical mapping (ICE-3D) to avoid fluoroscopy. METHODS: Twenty-six patients (47 ± 17 years old; 52% males; median ejection fraction 55 ± 13%) with premature ventricular contractions or ventricular tachycardia underwent catheter ablation. VAs were localized using ICE-3D with arrhythmia foci being mapped at the LVS. Focal ablation was performed using a 3.5-mm open-irrigated, contact force sensing radiofrequency catheter. RESULTS: Acute success and recurrence rates were 84% and 24%, respectively. Holter burden was significantly reduced (24 ± 15% to 1.5 ± 2%; P = 0.01) after ablation. The use of zero fluoroscopy was achieved in 100% of cases. No major complications were observed. CONCLUSIONS: Zero fluoroscopy catheter ablation of LVS VAs using ICE-3D mapping is feasible and effective.
Authors: Pasquale Santangeli; Francis E Marchlinski; Erica S Zado; Daniel Benhayon; Mathew D Hutchinson; David Lin; David S Frankel; Michael P Riley; Gregory E Supple; Fermin C Garcia; Rupa Bala; Benoit Desjardins; David J Callans; Sanjay Dixit Journal: Circ Arrhythm Electrophysiol Date: 2015-01-30
Authors: Mansour Razminia; Marian F Manankil; Paula L S Eryazici; Carlos Arrieta-Garcia; Theodore Wang; Oliver J D'Silva; Christian S Lopez; George J Crystal; Saba Khan; Mihaela M Stancu; Marianne Turner; Joseph Anthony; Terry A Zheutlin; Richard F Kehoe Journal: J Cardiovasc Electrophysiol Date: 2012-05-09
Authors: Federica Troisi; Pietro Guida; Federico Quadrini; Antonio Di Monaco; Nicola Vitulano; Rosa Caruso; Rocco Orfino; Giacomo Cecere; Matteo Anselmino; Massimo Grimaldi Journal: Front Cardiovasc Med Date: 2022-04-28
Authors: Carlo Lavalle; Marco V Mariani; Agostino Piro; Martina Straito; Paolo Severino; Domenico G Della Rocca; Giovanni B Forleo; Jorge Romero; Luigi Di Biase; Francesco Fedele Journal: J Interv Card Electrophysiol Date: 2019-10-24 Impact factor: 1.900
Authors: Grzegorz Karkowski; Marcin Kuniewicz; Edward Koźluk; Tomasz Chyży; Andrzej Ząbek; Michał Dusza; Jacek Lelakowski Journal: Postepy Kardiol Interwencyjnej Date: 2020-10-02 Impact factor: 1.426
Authors: Guram Imnadze; Thomas Zerm; Mustapha El Hamriti; Leonard Bergau; Martin Braun; Moneeb Khalaph; Christian Sohns; Philipp Sommer Journal: Cardiol J Date: 2021-10-21 Impact factor: 2.737